PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $252,899 | -11.6% | 114,434 | +1.6% | 0.00% | – |
| Q1 2023 | $286,162 | +38.3% | 112,662 | +1.8% | 0.00% | – |
| Q4 2022 | $206,949 | -27.6% | 110,668 | -0.5% | 0.00% | – |
| Q3 2022 | $286,000 | +37.5% | 111,243 | +3.3% | 0.00% | – |
| Q2 2022 | $208,000 | -84.4% | 107,717 | -76.0% | 0.00% | – |
| Q1 2022 | $1,335,000 | -36.3% | 449,337 | -3.7% | 0.00% | – |
| Q4 2021 | $2,096,000 | -7.6% | 466,797 | -0.0% | 0.00% | – |
| Q3 2021 | $2,269,000 | -30.8% | 466,871 | -2.9% | 0.00% | -100.0% |
| Q2 2021 | $3,280,000 | -4.5% | 481,062 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $3,433,000 | +2.9% | 486,290 | -8.8% | 0.00% | 0.0% |
| Q4 2020 | $3,336,000 | +14.4% | 532,952 | -1.1% | 0.00% | 0.0% |
| Q3 2020 | $2,915,000 | +0.0% | 538,937 | -3.5% | 0.00% | 0.0% |
| Q2 2020 | $2,914,000 | +118.1% | 558,378 | +31.6% | 0.00% | – |
| Q1 2020 | $1,336,000 | -16.9% | 424,142 | +6.4% | 0.00% | – |
| Q4 2019 | $1,608,000 | -12.7% | 398,800 | -6.5% | 0.00% | – |
| Q3 2019 | $1,842,000 | +11.4% | 426,389 | +2.9% | 0.00% | – |
| Q2 2019 | $1,653,000 | -24.8% | 414,364 | +1.1% | 0.00% | -100.0% |
| Q1 2019 | $2,197,000 | +3.7% | 409,847 | -0.7% | 0.00% | 0.0% |
| Q4 2018 | $2,119,000 | -49.5% | 412,916 | -4.4% | 0.00% | 0.0% |
| Q3 2018 | $4,192,000 | +0.5% | 432,090 | +5.7% | 0.00% | 0.0% |
| Q2 2018 | $4,170,000 | -11.2% | 408,846 | +13.1% | 0.00% | 0.0% |
| Q1 2018 | $4,698,000 | -17.9% | 361,406 | +13.0% | 0.00% | 0.0% |
| Q4 2017 | $5,725,000 | -30.4% | 319,798 | -2.4% | 0.00% | -50.0% |
| Q3 2017 | $8,223,000 | +3.5% | 327,617 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $7,946,000 | +57.6% | 329,693 | +25.9% | 0.00% | +100.0% |
| Q1 2017 | $5,041,000 | +33.4% | 261,899 | +6.7% | 0.00% | 0.0% |
| Q4 2016 | $3,780,000 | +28.3% | 245,394 | +8.3% | 0.00% | 0.0% |
| Q3 2016 | $2,947,000 | +22.5% | 226,581 | +31.0% | 0.00% | 0.0% |
| Q2 2016 | $2,406,000 | +15.0% | 172,979 | +25.5% | 0.00% | 0.0% |
| Q1 2016 | $2,092,000 | -18.1% | 137,871 | +2.4% | 0.00% | 0.0% |
| Q4 2015 | $2,555,000 | +7.7% | 134,678 | +7.8% | 0.00% | 0.0% |
| Q3 2015 | $2,373,000 | +388.3% | 124,922 | +563.6% | 0.00% | – |
| Q2 2015 | $486,000 | – | 18,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |